TB-500 Research for Wound Healing
An evidence-based overview of research examining TB-500 in the context of wound healing. This page synthesizes findings from peer-reviewed literature.
Research Summary
Thymosin beta-4's wound healing effects are among its most studied properties. The peptide increases re-epithelialization by 42-61% in rat wound models (Malinda et al., 1999), promoting both keratinocyte and fibroblast migration. The mechanism involves actin sequestration, allowing cells to become more mobile and migrate to wound sites. Additional benefits include stimulation of collagen production and extracellular matrix formation. Venous-ulcer clinical research concerns full-length thymosin beta-4, not TB-500. A quantified healing-time advantage requires direct outcome-paper verification before being presented as a result.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Always consult a healthcare provider before making health decisions.